decisionhealth Newsletters, Coder Pink Sheets - 2002 Issue 8 (August)
Fecal occult test
Subscribe or sign in to view the full article.
Article Overview
This short Find-A-Code article explains a CMS program update involving an FDA-approved CLIA-waived fecal occult blood test and the related billing identifier. It is relevant to coders, billing staff, compliance teams, and laboratory/diagnostic practices that work with Medicare claims and waived testing requirements. The article provides a concise notice about the policy update, the test context, and the organization guidance tied to the effective date.
Why This Topic Matters
Updates like this affect how diagnostic tests are reported and recognized for Medicare reimbursement and compliance purposes. Readers need the article to understand the scope of the policy change and the associated coding reference without relying on assumptions.
What You Will Learn
- The general Medicare/CMS context for a CLIA-waived fecal occult blood test update
- Which organizations and policy sources are mentioned in the notice
- The effective date associated with the update
- How the article frames the related billing identifier in the context of waived testing
Who Should Read This
- Medical coders
- Billing staff
- Compliance personnel
- Laboratory managers
- Healthcare administrators
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com